Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Eur J Clin Pharmacol. 2012 Jul 10;69(3):439–448. doi: 10.1007/s00228-012-1339-x

Fig. 5.

Fig. 5

Relative change in CYP3A activity based on CYP3A5 genotype. The relative change in intestinal (a) and hepatic (b) CYP3A activity was assessed in CYP3A5 high expressers (n=4, white bars) and low expressers (n=8, black bars). Data are presented as the mean ± SE. *p=0.046 compared to baseline activity